(RightWing.org) – President Donald Trump has championed the safe use of the antimalarial drug hydroxychloroquine (HCQ) to treat COVID-19. He even started taking it himself to see if it would protect him from contracting the virus and other world leaders followed his examples. The president’s critics, however, pointed to a study that claimed the medication was dangerous to “prove” he was wrong. Well, now that study is being retracted.
The study in question was widely used to discredit the use of the medication. It reportedly found hydroxychloroquine and chloroquine did not improve outcomes for patients with the coronavirus, and it led to higher mortality rates.
On June 4, one of the top medical journals, The Lancet, announced they were retracting it. The authors of the study are concerned about the underlying data and sources. Frank Ruschitzka of University Hospital Zurich, Mandeep Mehra of Brigham and Women’s Hospital and Amit Patel of the University of Utah said they “can no longer vouch” for the accuracy of the data. Surgisphere, the company that collected the information, refused to cooperate with audits and did not provide the data. That left the authors unable to verify it.
So Surgisphere Corp was caught falsifying data for the Lancet study on hydroxychloroquine
Hospitals deny ever sharing patient data w/ this mysterious database
When asked to reveal the hospitals the data came from, Surgisphere refused
Is this real life?https://t.co/mvoBpE8IrE
— James Todaro, MD (@JamesTodaroMD) May 28, 2020
Does that mean the medication works? The jury is still out on that. However, it does raise questions about how many people might have been saved had the media not jumped so quickly to use one flawed study to discredit the president.
Copyright 2020, RightWing.org